Answer in brief
CVE-2026-123052 records a Medium severity (CVSS 4.7) vulnerability in Shared Hard-Coded OAuth Credentials Across Farmasimplex CeliachiaRL Installations. The current sources do not mark it as known exploited. The current feed maps CIPCarbone/Farmasimplex CeliachiaRL (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 4.7. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps CIPCarbone/Farmasimplex CeliachiaRL (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| CIPCarbone/Farmasimplex CeliachiaRLgeneric | >=0 <16.2.0 | 16.2.0 |
Published upstream
Nov 17, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Nov 17, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Nov 17, 2026
The CeliachiaRL integration component distributed with Farmasimplex uses shared OAuth credentials across multiple customer installations. An attacker who obtains the credentials from one installation could reuse them against services associated with other installations, potentially leading to unauthorized access to sensitive information or modification of integration data.
Quoted source text, attributed separately from HOL analysis.